好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Community Health Worker Integration into Migraine Care: A Model for Scalable Migraine Screening
Headache
P9 - Poster Session 9 (5:00 PM-6:00 PM)
15-013
Explore using community health worker (CHW) expertise for migraine screening in the community and triage level of care.

CHWs are trained individuals acting as public health liaisons to improve the overall community health. Several medical societies have identified their importance and utilized their expertise for screening, testing and referrals of appropriate patients.

Despite advances in care, the overall prevalence and burden of migraine has remained unchanged over the last few decades. In the OVERCOME (US) 2018 cohort study, only 51% of respondents with migraine had a migraine consultation within the past year. This lack of progress highlights the need for early identification and management of this disease in the community.
This is a retrospective chart review of data from a pharmacy-based quality improvement service. Pharmacy-based CHWs screened consecutive community members for migraine using the ID migraine and estimated the migraine-related lost productive time (LPT) at work, which was calculated as the days missed work + 0.5 x (number of days with reduced productivity by at least half). R version 4.4.0 was used for statistical analysis.
CHWs screened 137 individuals (38 men and 93 women) with an average age of 67.9. Of these, 39 (28.5%) individuals had headaches. Of those who had a headache, 12 individuals (30.7%) screened positive for migraine, and 5 (41.7%) of those did not have a prior headache diagnosis. Two individuals (13%) reported reduced productivity at work due to headaches. Only 8 (46%) of individuals with diagnosed migraine were prescribed medications.
CHW screening was able to successfully identify individuals who screened positively on ID-Migraine without a previous headache diagnosis and individuals with an established diagnosis who were not receiving treatment. Integration of CHWs into migraine care can identify individuals with migraine who require access to headache care. Further studies are needed to assess scalability of this approach.
Authors/Disclosures
Medha Tandon, MBBS
PRESENTER 		Dr. Tandon has nothing to disclose.
Olivia Begasse De Dhaem, MD (Institute for Headache and Brain Health) Dr. Begasse De Dhaem has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Begasse De Dhaem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for JOGO. Dr. Begasse De Dhaem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Begasse De Dhaem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine Journal. Dr. Begasse De Dhaem has received publishing royalties from a publication relating to health care.
John Galdo, PharmD, MBA An immediate family member of Dr. Galdo has received personal compensation for serving as an employee of Eli Lilly. Dr. Galdo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Galdo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Seguridad, Inc.
Richard N. Logan, PharmD Dr. Logan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for IMS.
Courtney Hahs, PharmD Dr. Hahs has nothing to disclose.
Kelsey L. Holder, PharmD Dr. Holder has nothing to disclose.
Amaal J. Starling, MD, FAAN (Mayo Clinic) Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .